Search results

Virtual activities celebrating the benefits of nuclear science and technology held for National Science Week

Consumers want to know that the foods they consume provide health benefits. Food materials science can monitor changes during digestion as well as assist in the development of low-fat products.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

An international research team has discovered how a bacterial toxin, known as Ssp, is capable of entering and killing a wide range of living cells, including human cells using the Australian Synchrotron.

The mechanical, electrical, chemical, optical and thermal properties of glass, as determined by its chemical composition and atomic structure, make it a highly useful material with a myriad of applications.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

There have been significant developments in small modular reactor technologies in 2022. The International Atomic Energy Agency expects small modular reactors (SMRs) to make an important contribution to achieving global climate goals and energy supply security. But with more than 70 SMR designs under development in 18 countries – including innovative reactors that are yet to be licensed and novel methods of modular manufacturing that are new to the nuclear industry – widely deploying SMRs in time remains a tall task.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Quantum theory explains the strange and unpredictable behaviour of subatomic particles and the smallest amounts of energy.

ANSTO has contributed to international research on quasicrystals that opens the door to tailored magnetic materials.

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.